BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16725267)

  • 1. Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data.
    Bohlius J; Tonia T; Nüesch E; Jüni P; Fey MF; Egger M; Bernhard J
    Br J Cancer; 2014 Jul; 111(1):33-45. PubMed ID: 24743705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey.
    Steegmann JL; Sánchez Torres JM; Colomer R; Vaz Á; López J; Jalón I; Provencio M; González-Martín A; Pérez M
    Clin Transl Oncol; 2013 Jun; 15(6):477-83. PubMed ID: 23263906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualizing anaemia therapy.
    de Francisco AL
    NDT Plus; 2010 Dec; 3(6):519-26. PubMed ID: 25949459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer- and chemotherapy-induced anemia.
    Rodgers GM; Becker PS; Blinder M; Cella D; Chanan-Khan A; Cleeland C; Coccia PF; Djulbegovic B; Gilreath JA; Kraut EH; Matulonis UA; Millenson MM; Reinke D; Rosenthal J; Schwartz RN; Soff G; Stein RS; Vlahovic G; Weir AB
    J Natl Compr Canc Netw; 2012 May; 10(5):628-53. PubMed ID: 22570293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of chemotherapy-induced anemia].
    Kadokura G; Katsumata N
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):416-20. PubMed ID: 24743356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of red blood cells with multiwavelength transmission spectroscopy.
    Serebrennikova YM; Huffman DE; Garcia-Rubio LH
    Biomed Res Int; 2015; 2015():382641. PubMed ID: 25654099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece.
    Nikolaidi E; Hatzikou M; Geitona M
    Cost Eff Resour Alloc; 2013 Jul; 11(1):16. PubMed ID: 23870502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoiesis-stimulating agents in patients with cancer: update on safety issues.
    Pirker R
    Expert Opin Drug Saf; 2009 Sep; 8(5):515-22. PubMed ID: 19637988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European guidelines for the management of chemotherapy-induced anaemia and health economic aspects of treatment.
    Repetto L; Moeremans K; Annemans L;
    Cancer Treat Rev; 2006; 32 Suppl 2():S5-9. PubMed ID: 16725267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents.
    Aapro MS; Link H
    Oncologist; 2008; 13 Suppl 3():33-6. PubMed ID: 18458123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model.
    Borg S; Glenngård AH; Osterborg A; Persson U
    Acta Oncol; 2008; 47(6):1009-17. PubMed ID: 18770060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health care.
    Arbuckle RB; Griffith NL; Iacovelli LM; Johnson PE; Jorgenson JA; Kloth DD; Lucarelli CD; Muller RJ
    Pharmacotherapy; 2008 May; 28(5 Pt 2):1S-15S. PubMed ID: 18447704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR
    Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.